Repligen Has Launched the CTech™ SoloVPE® PLUS System
References: globenewswire
Repligen has launched the CTech™ SoloVPE® PLUS System, an advanced UV-based concentration measurement tool for biopharmaceutical production. This system addresses the growing need for efficient, reliable, and accurate analytical solutions in the bioprocessing industry, where drug formulations are becoming more concentrated to enhance efficiency and reduce costs.
Repligen's device promises to streamline workflows, improve rates of data acquisition and overall sensitivity, as well as minimize user error. The CTech™ SoloVPE® PLUS System is capable of measuring concentrations in under 30 seconds without requiring dilution or background correction. This makes the concentration measurement tool faster and more precise compared to previous systems.
The system supports the analysis of protein concentrations, including antibody-drug conjugates, as well as nucleic acid quantification. This is essential for emerging therapeutics like mRNA vaccines.
Image Credit: Repligen
Repligen's device promises to streamline workflows, improve rates of data acquisition and overall sensitivity, as well as minimize user error. The CTech™ SoloVPE® PLUS System is capable of measuring concentrations in under 30 seconds without requiring dilution or background correction. This makes the concentration measurement tool faster and more precise compared to previous systems.
The system supports the analysis of protein concentrations, including antibody-drug conjugates, as well as nucleic acid quantification. This is essential for emerging therapeutics like mRNA vaccines.
Image Credit: Repligen
Trend Themes
1. Rapid Concentration Measurement Technologies - The development of accelerated measurement tools that deliver results in under 30 seconds showcases a shift toward real-time analytical capabilities in biopharmaceutical settings.
2. Non-dilution Analysis Advancements - By eliminating the need for dilution in concentration measurement, new systems are simplifying processes and enhancing precision in biochemical and pharmaceutical research.
3. High-sensitivity Analytical Equipment - The trend towards more sensitive measuring devices offers greater accuracy in quantifying complex biomolecules, essential for the next generation of therapeutics.
Industry Implications
1. Bioprocessing Equipment Manufacturing - The demand for more efficient, non-invasive analytical tools is driving innovations in equipment production tailored for high-precision biopharmaceutical applications.
2. Pharmaceutical R&D - Research and development in the pharmaceutical industry are being transformed by advanced concentration analysis technologies that accelerate drug formulation processes.
3. Biotechnology Solutions - Biotechnology firms are exploring specialized measurement solutions to support advancements in genetic and protein-based therapies, including mRNA vaccines.
3.4
Score
Popularity
Activity
Freshness
